Primary gastric Hodgkin's lymphoma expressing a B-cell profile including Oct-2 and Bob-1 proteins

International Journal of Hematology

Volumn 85, Issue 5, 2007, Pages 421-425

  Saito, Makoto ^a,b   Tanaka, Shinya ^b   Mori, Akio ^a   Toyoshima, Nobuyasu ^a   Irie, Tatsuro ^a   Morioka, Masanobu ^a  

^a JAPANESE RED CROSS SOCIETY   (Japan)

^b HOKKAIDO UNIVERSITY   (Japan)

Author keywords

Bob 1; Hodgkin's lymphoma; Immunohistochemistry; Oct 2; Stomach

Indexed keywords

ANAPLASTIC LYMPHOMA KINASE; ANAPLASTIC LYMPHOMA KINASE 1; BLEOMYCIN; CD15 ANTIGEN; CD20 ANTIGEN; CD3 ANTIGEN; CD30 ANTIGEN; CD45 ANTIGEN; CD79A ANTIGEN; DACARBAZINE; DOXORUBICIN; EPITHELIAL MEMBRANE ANTIGEN; LYMPHOCYTE SURFACE MARKER; OCTAMER TRANSCRIPTION FACTOR 2; PROTEIN BOB1; UNCLASSIFIED DRUG; VINBLASTINE; ABVD PROTOCOL; ANTINEOPLASTIC AGENT; BIOLOGICAL MARKER; POU2AF1 PROTEIN, HUMAN; TRANSACTIVATOR PROTEIN;

ABDOMINAL RADIOGRAPHY; AGED; ANOREXIA; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER REGRESSION; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; GASTRECTOMY; GASTROSCOPY; HISTOPATHOLOGY; HODGKIN DISEASE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; JAPAN; PARAAORTIC LYMPH NODE; PROTEIN EXPRESSION; STOMACH LYMPHOMA; STOMACH ULCER; SYMPTOM; B LYMPHOCYTE; METABOLISM; PATHOLOGY; REMISSION; STOMACH TUMOR;

AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; B-LYMPHOCYTES; BIOLOGICAL MARKERS; BLEOMYCIN; DACARBAZINE; DOXORUBICIN; FEMALE; GASTRECTOMY; HODGKIN DISEASE; HUMANS; IMMUNOHISTOCHEMISTRY; OCTAMER TRANSCRIPTION FACTOR-2; REMISSION INDUCTION; STOMACH NEOPLASMS; TRANS-ACTIVATORS; VINBLASTINE;

EID: 34548439450     PISSN: 09255710     EISSN: None     Source Type: Journal    
DOI: 10.1532/IJH97.06094     Document Type: Article

References (28)

1. Jaffe ES, Harris NL, Stein H, Vardiman JW, eds. World Health Organization Classification of Tumours. Pathology & Genetics: Tumours of Haematopoietic and Lymphoid Tissues. Lyon, France: IARC Press; 2001.
2. Wood NL, Coltman CA. Localized primary extranodal Hodgkin's disease. Ann Intern Med. 1973;78:113-118.
3. Devancy K, Jaffe ES. The surgical pathology of gastrointestinal Hodgkin disease [abstract]. American Society of Clinical Pathologists and College of American Pathologists Annual Meeting, New Orleans, Louisiana. 1990;93:449. Abstract 73.
4. Colucci G, Giotta F, Maiello E, Fucci L, Caruso ML. Primary Hodgkin's disease of the stomach: a case report. Tumori. 1992;78:280-282.
5. Mori N, Yatabe Y, Narita M, et al. Primary gastric Hodgkin's disease: morphologic, immunohistochemical, and immunogenetic analyses. Arch Pathol Lab Med. 1995;119:163-166.
6. Ogawa Y, Chung YS, Nakata B, et al. A case of primary Hodgkin's disease of the stomach. J Gastroenterol. 1995;30:103-107.
7. Doweiko J, Dezube BJ, Pantanowitz L. Unusual sites of Hodgkin's lymphoma, case 1: HIV-associated Hodgkin's lymphoma of the stomach. J Clin Oncol. 2004;22:4227-4228.
8. Küppers R, Rajewsky K, Zhao M, et al. Hodgkin's disease: Hodgkin and Reed-Sternberg cells picked from histological sections show clonal immunoglobulin gene rearrangements and appear to be derived from B cells at various stages of development. Proc Natl Acad Sci U S A. 1994;91:10962-10966.
9. Tamaru J, Hummel M, Zemlin M, Kalvelage B, Stein H. Hodgkin's disease with a B-cell phenotype often shows a VDJ rearrangement and somatic mutations in the VH genes. Blood. 1994;84:708-715.
10. Hummel M, Ziemann K, Lammert H, Pileri S, Sabattini E, Stein H. Hodgkin's disease with monoclonal and polyclonal populations of Reed-Sternberg cells. N Engl J Med. 1995;333:901-906.
11. Re D, Thomas RK, Behringer K, Diehl V. From Hodgkin disease to Hodgkin lymphoma: biologic insights and therapeutic potential. Blood. 2005;105:4553-4560.
12. Küppers R, Klein U, Hansmann ML, Rajewsky K. Cellular origin of human B-cell lymphomas. N Engl J Med. 1999;341:1520-1529.
13. Korkolopoulou P, Cordell J, Jones M, et al. The expression of the B-cell marker mb-1 (CD79a) in Hodgkin's disease. Histopathology. 1994;24:511-515.
14. von Wasielewski R, Mengel M, Fischer R, et al. Classical Hodgkin's disease: clinical impact of the immunophenotype. Am J Pathol. 1997;151:1123-1130.
15. Re D, Müdiger T, Marx A, Müschen M, Ahmadi T, et al. Oct-2 and Bob-1 deficiency in Hodgkin and Reed Sternberg cells. Cancer Res. 2001;61:2080-2084.
16. Stein H, Marafioti T, Foss HD, et al. Down-regulation of BOB.1/OBF.1 and Oct2 in classical Hodgkin's disease but not in lymphocyte predominant Hodgkin disease correlates with immunoglobulin transcription. Blood. 2001;97:496-501.
17. Loddenkemper C, Anagnostopoulos I, Hummel M, et al. Differential Eμ enhancer activity and expression of BOB.1/OBF.1, Oct2, PU.1, and immunoglobulin in reactive B-cell populations, B-cell non-Hodgkin lymphomas, and Hodgkin lymphomas. J Pathol. 2004;202:60-69.
18. Garcia-Cosio M, Santon A, Martin P, et al. Analysis of transcription factor OCT.1, OCT.2 and BOB.1 expression using tissue arrays in classical Hodgkin's lymphoma. Mod Pathol. 2004;17:1531-1538.
19. Orba Y, Tanaka S, Nishihara H, et al. Application of laser capture microdissection to cytologic specimens for the detection of immunoglobulin heavy chain gene rearrangement in patients with malignant lymphoma. Cancer. 2003;99:198-204.
20. Foss HD, Reusch R, Demel G, et al. Frequent expression of the B-cell-specific activator protein in Reed-Sternberg cells of classical Hodgkin's disease provides further evidence for its B-cell origin. Blood. 1999;94:3108-3113.
21. + anaplastic large cell lymphoma: a review of its histopathologic, genetic, and clinical features. Blood. 2000;96:3681-3695.
22. Lai R, Medeiros LJ, Dabbagh L, Formenti KS, Coupland RW. Sinusoidal CD30-positive large B-cell lymphoma: a morphologic mimic of anaplastic large cell lymphoma. Mod Pathol. 2000;13:223-228.
23. Haralambieva E, Pulford KA, Lamant L, et al. Anaplastic large-cell lymphomas of B-cell phenotype are anaplastic lymphoma kinase (ALK) negative and belong to the spectrum of diffuse large B-cell lymphomas. Br J Haematol. 2000;109:584-591.
24. Garcia JF, Mollejo M, Fraga M, et al. Large B-cell lymphoma with Hodgkin's features. Histopathology. 2005;47:101-110.
25. Brauninger A, Hansmann ML, Strickler JG, et al. Identification of common germinal-center B-cell precursors in two patients with both Hodgkin's disease and non-Hodgkin's lymphoma. N Engl J Med. 1999;340:1239-1247.
26. Zettl A, Rüdiger T, Marx A, Müller-Hermelink HK, Ott G. Composite marginal zone B-cell lymphoma and classical Hodgkin's lymphoma: a clinicopathological study of 12 cases. Histopathology. 2005;46:217-228.
27. Knowles DM. Immunodeficiency-associated lymphoproliferative disorders. Mod Pathol. 1999;12:200-217.
28. + B-cell lymphoproliferative disorders: a clinicopathologic study of 22 patients. Am J Surg Pathol. 2003;27:16-26.